Listen to insights on the most up-to-date haematology data, as discussed by experts in the field.
Learn more about the key data highlights presented at congresses and how they could impact UK clinical practice.
For full details, please refer to the Gazyvaro® Summary of Product Characteristics.
1L, first-line; CLL, chronic lymphocytic leukaemia; FL, follicular lymphoma; R/R, relapsed/refractory.
Date of preparation: November 2019